[Value of tumor markers in surveillance of primary bronchial cancers and to evaluate therapy].
Sculier
J P
JP
Service de Médecine et Laboratoire d'Investigation Clinique H.J. Tagnon, Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles.
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D002283:Carcinoma, Bronchogenic / Q000175:diagnosis / Q000628:therapy*; D016903:Drug Monitoring; D006801:Humans; D053539:Keratin-19; D007633:Keratins; D008175:Lung Neoplasms / Q000175:diagnosis / Q000628:therapy*; D010751:Phosphopyruvate Hydratase; D016896:Treatment Outcome
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D053539:Keratin-19; C102012:antigen CYFRA21.1; D007633:Keratins; D010751:Phosphopyruvate Hydratase